EDAP TMS Publishes HIFI Study Results In European Urology
EDAP TMS Publishes HIFI Study Results In European Urology
edap tms 發佈了在歐洲泌尿學期刊上進行的HIFI研究結果
- HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatments
- Positive study results are expected to drive further adoption of Focal One as a first line treatment option for the management of localized prostate cancer
- Study shows Focal One Robotic HIFU is non-inferior to surgery, meeting primary endpoint of non-inferiority for Salvage Treatment-free Survival (STFS) after High Intensity Focused Ultrasounds (HIFU) compared to Radical Prostatectomy (RP) at 30 months
- Study shows that patients receiving HIFU had better outcomes with respect to urinary continence and erectile function compared to patients receiving RP
- HIFI研究是最大的（N = 3,328）前瞻性、比較性、多中心臨床研究，比較前列腺癌治療方案
- 積極的研究結果有望推動Focal One作爲局部前列腺癌管理的一線治療選擇的進一步應用
- 研究表明，Focal One機器人HIFU在治癒率方面不遜色於手術，滿足在高強度聚焦超聲（HIFU）之後，救助治療無生存期（STFS）與根治性前列腺切除術（RP）比較的非劣性主要終點，在30個月時
- 研究表明，接受HIFU治療的患者在尿失禁和勃起功能方面的結果優於接受RP治療的患者
資訊熱榜
更新時間